27
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Resistance of lymphocytes to Fas-mediated apoptosis in Behçet's disease and Vogt-Koyangi-Harada syndrome

, , , , , & show all
Pages 47-52 | Published online: 08 Jul 2009

References

  • Li S, Yang P. Uveitis in China. Ocu/ Immunol Want 1994;2: 247–252.
  • Nussenblatt RB, Whitcup SM, Palestine AG, editors. Uveitis fundamentals and clinical practice. St.Louis: Mosby, 1996;312–353.
  • Whitcup SM. The initiating stimuli for uveitis. Eye. 1997;1i:167–170.
  • International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1078–1080.
  • Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980;90:69–75.
  • Shounan Y, Feng X, O'Connell PJ. Apoptosis detection by annexin V binding, a novel method for the quantitation of cell-mediated cytotoxicity. J Immunol Methods. 1998;217:61–70.
  • Van-Engeland M, Nieland Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 1998;31:1–9.
  • Fukuzuka K, Edwards CK, Clare-Salzler M, Copeland EM, Moldawer LL, Mozingo DW. Glucocorticoid-induced, caspase-dependent organ apoptosis early after burn injury. Am J PhysioL 2000;278: I 005–1018.
  • Owen-Schaub LB, Yonehara S, Crump III WL, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol. 1992; 140:197–205.
  • Martinez-Lorenzo MI Anel A, Gamen S, Monleon I, Lasierra P, Larrad L, et al. Activated human T cells release bioactive Fas ligand and AP02 ligand in microvesicles. J Immunol. 1999;163:1274–1281.
  • Chan CC, Caspi RR, Ni M, Leake WC, Wiggert B, Chader GI et al. Pathology of experimental uveoretinitis in mice. J Autoimmun. 1990;3:247–255.
  • Caspi RR, Chan CC, Wiggert B, Chader GI The mouse as a model of experimental autoimmune uveoretinitis (EAU). Curr Eye Res. 1990;9(Suppl):169–174.
  • Sueda J, Hikita N, Mochizuki M, Jimi A, Kojiro M. Kinetics of apoptotic cells in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 2000;41:799–804.
  • Yang P, Herzberg NH, Zhou H, Broersma L, De Smet M, Kijlstra A. Apoptosis of infiltrating cells in experimental autoimmune uveoretinitis. Chin Med J. 2000;13: 643–646.
  • Yu HG, Chung H, Lee WI Apoptosis of CD4+ T cell occurs in experimental autoimmune anterior uveitis (EAAU). Clin Exp Immunol. 1999;118:357–363.
  • Smith JR, Hart PH, Standfield SD, Coster DJ, Wing SI Williams KA. Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol. 2000;84: 205–211.
  • Wahlsten JL, Gitchell HL, Chan CC, Wiggert B, Caspi RR. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis. J Immunol. 2000;165:5480–5486.
  • Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand induced apoptosis as a mechanism of immune privilege. Science. 1995; 270:1189–1192.
  • Yang P, Ji L, Zhou H, Huang X, Xie C, Jin H, et al. Disturbed expression of Fas/FasL on CD4+ and CD8+ T cells in Behcet's disease, Vogt-Koyanagi-Harada syndrome and idiopathic anterior uveitis. Ocul Immunol Want. 2001;9(3): 185–191.
  • Howie SE, Harrison DJ, Wyllie AH. Lymphocyte apoptosis-mechanisms and implications in disease. Immunol Rev. 1994;142:141–i6.
  • Sato T, Irie S, Kitada S, Reed JC. FAP-I: A protein tyrosine phosphatase that associates with Fas. Science. 1995;268:411–415.
  • Gery I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and immunopathogenic processes they provoke. In: Osborne N, Chader J, editors. Progress in retina research. New York: Pergamon Press, 1986; 75–109.
  • Broekhuyse RM, Kuhlmann ED, Winkens HI Van Vugt AHM. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis. I. Induction by a detergent-insoluble, intrinsic protein fraction of the retina pigment epithelium. Exp Eye Res. 1991;52:465–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.